Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exploring patient and public involvement in motor neuron disease research.
Musson LS, McDermott CJ, Hobson EV. Musson LS, et al. Among authors: mcdermott cj. Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(7-8):511-520. doi: 10.1080/21678421.2019.1643373. Epub 2019 Aug 2. Amyotroph Lateral Scler Frontotemporal Degener. 2019. PMID: 31373235 Free article.
Evidence-based or arrogance-based medicine?
Rafiq MK, Mcdermott C, Shaw P. Rafiq MK, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(3-4):305-6. doi: 10.3109/21678421.2016.1140211. Epub 2016 Feb 17. Amyotroph Lateral Scler Frontotemporal Degener. 2016. PMID: 26883472 No abstract available.
The TiM system: developing a novel telehealth service to improve access to specialist care in motor neurone disease using user-centered design.
Hobson EV, Baird WO, Partridge R, Cooper CL, Mawson S, Quinn A, Shaw PJ, Walsh T, Wolstenholme D, Mcdermott CJ. Hobson EV, et al. Among authors: mcdermott cj. Amyotroph Lateral Scler Frontotemporal Degener. 2018 Aug;19(5-6):351-361. doi: 10.1080/21678421.2018.1440408. Epub 2018 Feb 16. Amyotroph Lateral Scler Frontotemporal Degener. 2018. PMID: 29451026 Free article.
Physicians' attitudes toward end-of-life decisions in amyotrophic lateral sclerosis.
Thurn T, Borasio GD, Chiò A, Galvin M, McDermott CJ, Mora G, Sermeus W, Winkler AS, Anneser J. Thurn T, et al. Among authors: mcdermott cj. Amyotroph Lateral Scler Frontotemporal Degener. 2019 Feb;20(1-2):74-81. doi: 10.1080/21678421.2018.1536154. Epub 2019 Feb 21. Amyotroph Lateral Scler Frontotemporal Degener. 2019. PMID: 30789031
The relationships between symptoms, disability, perceived health and quality of life in amyotrophic lateral sclerosis/motor neuron disease.
Young CA, Ealing J, McDermott C, Williams T, Al-Chalabi A, Majeed T, Burke G, Pinto A, Dick D, Talbot K, Harrower T, Walsh J, Chandran S, Hanemann CO, Mills R, Tennant A. Young CA, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):317-327. doi: 10.1080/21678421.2019.1615951. Epub 2019 May 22. Amyotroph Lateral Scler Frontotemporal Degener. 2019. PMID: 31116037
Optimizing the noninvasive ventilation pathway for patients with amyotrophic lateral sclerosis/motor neuron disease: a systematic review.
Baxter SK, Johnson M, Clowes M, O'Brien D, Norman P, Stavroulakis T, Bianchi S, Elliott M, McDermott C, Hobson E. Baxter SK, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(7-8):461-472. doi: 10.1080/21678421.2019.1627372. Epub 2019 Jun 16. Amyotroph Lateral Scler Frontotemporal Degener. 2019. PMID: 31204525 Free article.
228 results